Phoenix, Arizona — Phoenix, Arizona

Phoenix, Arizona is a clinical research site located in Phoenix, Arizona, United States 85012-2707.

Crixeo Health Trust Score: 61/100 (FAIR). This profile has not yet been claimed by the site owner.

Phoenix, Arizona has participated in 3 clinical trials with 1 currently active.

Therapeutic areas: Schizophrenia, Diabetic Macular Edema (DME), Panic Disorder.

Sponsors: AbbVie, EyeBiotech Ltd..

Sponsor Feasibility Report

Trust Score: 61/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Phoenix, Arizona?

Phoenix, Arizona has a Crixeo Trust Score of 61/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Phoenix, Arizona conducted?

Phoenix, Arizona has 3 clinical trials on record, with 1 currently active. Their work covers Schizophrenia, Diabetic Macular Edema (DME), Panic Disorder.

Is Phoenix, Arizona accredited by Crixeo Health?

Phoenix, Arizona has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Phoenix, Arizona?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.